Literature DB >> 10684367

A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy.

T Ogawa1, K Maruyama, H Hattori, H Arai, I Kondoh, T Egashira, T Watanabe, Y Kobayashi, A Morikawa.   

Abstract

We have previously reported an 8-year-old girl with lipoprotein glomerulopathy. Assessment of serum apolipoprotein E (apo E) in this patient showed a discrepancy between phenotype and genotype, suggesting that she may have a variant of apo E. The present report concerns our analysis of DNA sequences of the apo E gene in the patient: nine base pairs were found to be deleted from exon 4. This mutation would appear to encode a new apo E variant lacking three amino acids. This variant may be associated with the pathogenesis of lipoprotein glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684367     DOI: 10.1007/s004670050032

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Authors:  Yoshiro Miyahara; Shinsuke Nishimura; Maho Watanabe; Kenji Ito; Hitoshi Nakashima; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

2.  Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol.

Authors:  Hiroko Hamatani; Keiju Hiromura; Keiko Kobatake; Hiroaki Yoshida; Satsuki Kobayashi; Naohiro Yoneda; Ken Kayakabe; Takayuki Matsumoto; Takashi Kuroiwa; Kazue Ueki; Yoshihisa Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-15       Impact factor: 2.801

3.  Lipoprotein Glomerulopathy, First Case Report from Canada.

Authors:  Julie Anne Ting; Susanna A McRae; Daniel Schwartz; Sean J Barbour; Maziar Riazy
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-21

4.  Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.

Authors:  Atsunori Ishimura; Maho Watanabe; Hitoshi Nakashima; Kenji Ito; Katsuhisa Miyake; Shizue Mochizuki; Yasushi Ishigaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-21       Impact factor: 2.801

Review 5.  A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.

Authors:  Efstratios Stratikos; Angeliki Chroni
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

Review 6.  Lipoprotein glomerulopathy in China.

Authors:  Yuqing Chen
Journal:  Clin Exp Nephrol       Date:  2013-10-29       Impact factor: 2.801

7.  Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.

Authors:  Boxun Luo; Fengxian Huang; Qicai Liu; Xiaoyan Li; Wenfang Chen; Shu-Feng Zhou; Xueqing Yu
Journal:  Am J Nephrol       Date:  2007-11-29       Impact factor: 3.754

8.  Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.

Authors:  Satoshi Takasaki; Kunihiko Maeda; Kensuke Joh; Shu Yamakage; Sachiko Fukase; Toshiyuki Takahashi; Masayuki Suzuki; Akira Matsunaga; Takao Saito
Journal:  Case Rep Nephrol Dial       Date:  2015-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.